30 reports

The report provides the ##-year test volume and sales forecasts by country for HIV-##/ ##/ Combo, HIV Ag, HTLV-I/ II, Western Blot and other confirmatory tests performed in the following markets: - Hospitals - Public Health Labs - Commercial/ Private Labs &

  • Immunochemistry Test
  • Europe
  • Japan
  • United States
  • Demand

& nbsp; The report provides the ##-year test volume and sales forecasts by country for HIV-##/ ##/ Combo, HIVAg/ HIV NAT, HTLV-I/ II, Western Blot and other confirmatory tests performed in the following markets:- Hospitals - Public Health Labs - Commercial&

  • HIV AIDS
  • Immunochemistry Test
  • Europe
  • Germany
  • Demand

2016 Emerging Opportunities in the Japanese HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) JAPANESE AIDS TESTING MARKET Major Companies Developing or Marketi

  • Immunochemistry Test
  • Japan
  • Company Sales
  • Demand
  • Market Shares

2016 Emerging Opportunities in the Italian HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs, -- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) ITALIAN AIDS TESTING MARKET Major Companies Developing or Marketin

  • Immunochemistry Test
  • Italy
  • Company Sales
  • Demand
  • Market Shares

2016 Emerging Opportunities in the German HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs, -- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) GERMAN AIDS TESTING MARKET Major Companies Developing or Marketing

  • Immunochemistry Test
  • Germany
  • Company Sales
  • Demand
  • Market Shares

2016 Emerging Opportunities in the French HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) FRENCH AIDS TESTING MARKET Major Companies Developing or Marketing

  • Immunochemistry Test
  • France
  • Company Sales
  • Demand
  • Market Shares

2016 Emerging Opportunities in the Spanish HIV/ AIDS Diagnostics Market: Hospitals, Blood Banks, Commercial Labs-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures (DataPack) SPANISH AIDS TESTING MARKET Major Companies Developing or Marketing

  • Immunochemistry Test
  • Spain
  • Company Sales
  • Demand
  • Market Shares

ALERE DETERMINE IS A MULTIPLEXED HIV TEST ABLE TO DETECT BOTH HIV ##& ##-SPECIFIC ANTIBODIES AND HIV-## P## ANTIGEN.

  • Immunochemistry Test
  • North America
  • United States
  • Danaher Corporation
  • Roche Group
  • Market segmentation by application

In January 2014, the Health Resource and Services Administration HIV/ AIDS Bureau announced five new sources of funding through the Ryan White HIV/ AIDS Program.

  • Immunochemistry Test
  • United States
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • Roche Group

The rapid immunoassay product allows for the detection of HIV-## p## antigen and antibodies to HIV-##/ HIV-##.

  • Immunochemistry Test
  • Alere Inc.
  • Cepheid
  • Hologic, Inc.
  • Roche Group

Its Enzygnost HIV Integral ## assay provides a qualitative determination of HIV antibodies such as HIV-##, HIV-## group O, and HIV-##, plus p## antigen.

  • Immunochemistry Test
  • In Vitro Diagnostics
  • DiaSorin S.p.A.
  • Roche Group
  • Thermo Fisher Scientific, Inc.

There are approximately ##, ## people living with HIV/ AIDS in China.

  • Immunochemistry Test
  • United States
  • Grifols, S.A.
  • Hologic, Inc.
  • Immucor, Inc.

AIDS CASES).

  • Blood Supply
  • Hepatitis
  • Immunochemistry Test
  • Infectious Disease
  • China
  • 7.1 INTRODUCTION
  • HIV-1 SCREENING TESTS MARKET SIZE FOR HOME ACCESS DRIED BLOOD SPOTS, BY REGION, 2014-2021 (USD MILLION)

The HIV diagnosis market is projected to reach USD 3.88 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of 10.5% from 2016 to 2021. The global HIV diagnosis market is segmented based on product, test type, end user, and region. On the basis of product, the market is segmented into consumables (assays, kits, reagents, and other consumables),...

  • HIV Diagnostic
  • Immunochemistry Test
  • North America
  • United States
  • Market Size
  • Systems Laboratories (DSL), a provider of specialty immunoassays.

In 2007, Imperial College of London has given a grant to the company to develop quality assurance and quality control materials used to verify the accuracy of a planned point-of-care HIV/ AIDS test.

  • Immunochemistry Test
  • United States
  • Company
  • Deals & Alliance
  • Beckman Coulter, Inc.

Biomedical and life science research activities use antibodies for drug discovery and development and for developing diagnostic tools for various diseases, like cancer, HIV-AIDS, infectious diseases, and neurological disorders.

  • Immunochemistry Test
  • North America
  • United States
  • World
  • Merck & Co., Inc.
  • MARKET OVERVIEW
  • 10.4 ASIA

Fifth-generation ELISA offers the specific identification of individual positive HIV ## and HIV ## markers.

  • Immunochemistry Test
  • In Vitro Diagnostics
  • North America
  • United States
  • Forecast

The company' s flagship product, CD## BioChip system revolutionized the monitoring of treatment for HIV/ AIDS patients.

  • Drug Discovery And Development
  • Healthcare
  • Immunochemistry Test
  • United States
  • Company
  • ITALY: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)

This detects HIV-##, HIV-##, HBV, and HCV in transfused blood products.

  • HIV AIDS
  • Immunochemistry Test
  • North America
  • United States
  • Roche Group
  • 7.2.2 MARKET SEGMENTATION - BY DIAGNOSTIC - ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)

Autoimmune Disease Diagnostics Market The global autoimmune disease diagnostics market is expected to reach USD XXmillion by 2022 from USD XXmillion in 2016. During this period, the CAGR is expected to reach around XX%. There is an increasing prevalence of autoimmune disorders such as type 1 diabetes in newborn babies coupled with...

  • Immunochemistry Test
  • North America
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.

HIV/ AIDS, TUBERCULOSIS AND MALARIA).

  • Clinical Trial
  • Hormone
  • Hormones
  • Immunochemistry Test
  • Siemens Healthcare GmbH

The company" s lead drug candidate, BIT## is in Phase II clinical trials for the treatment of both HIV-## and Hepatitis C virus (HCV).

  • Clinical Trial
  • Colorectal Cancer
  • Immunochemistry Test
  • United States
  • Company

This has already been seen in HIV/ AIDS, and is likely to be replicated with NCDs. "

  • Immunochemistry Test
  • Oncology
  • Ovarian Cancer
  • United States
  • GlobalData's company

Pylori and syphilis, besides combination testing solutions for HIV-##/ ##, hepatitis B and C, and syphilis.

  • Clinical Trial
  • Diagnostics
  • Hormone
  • Immunochemistry Test
  • Siemens Healthcare GmbH

HIV/ AIDS and other life threatening diseases.

  • Cancer
  • Immunochemistry Test
  • Pancreatic Cancer
  • United States
  • Proteome Sciences

Immunoassays Markets

4091 4500 3477
  • EMERGING INTERNATIONAL MARKETS

FOR HIV, CHEMBIO OFFERS: DPP HIV ##/ ## ASSAY, SURE CHECK HIV ##/ ##, HIV ##/ ## STAT-PAK, AND HIV ##/ ## STAT-PAK DIPSTICK TESTS FOR THE RAPID, VISUAL DETECTION OF ANTIBODIES TO HIV ## AND

  • Biotech
  • Immunochemistry Test
  • United States
  • World
  • Company
  • EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE, 2013-2020 (USD MN)

The report analyzes the European enzyme immunoassay (EIA) Market by type, technique, end-user, and by country. The European enzyme immunoassay (EIA) market has been classified on the basis of types which mainly includes; EIA reagents & kits, and EIA analyzers. On the basis of technique the market is divided into; ELISA, rapid tests, and ELISPOT....

  • Immunochemistry Test
  • Europe
  • Western Europe
  • Demand
  • Beckman Coulter, Inc.

ITS LABORATORY TESTS INCLUDE FIBROMYALGIA, LASSA FEVER, GULF WAR SYNDROME, LUPUS, JUVENILE RA, GRAVES' DISEASE, BREAST CANCER AND NON-HIV AIDS.

  • Autoimmune Disease
  • Clinical Trial
  • Immunochemistry Test
  • In Vitro Diagnostic Reagent
  • GlobalData's company

The company detects and monitors life threatening viral diseases in the areas of cervical cancer, HIV/ AIDS, hepatitis, and organ transplant rejection.

  • Immunochemistry Test
  • Therapy
  • United States
  • Company
  • GlobalData's company

ITS LABORATORY TESTS INCLUDE FIBROMYALGIA, LASSA FEVER, GULF WAR SYNDROME, LUPUS, JUVENILE RA, GRAVES' DISEASE, BREAST CANCER AND NON-HIV AIDS.

  • Biomarker
  • Breast Cancer
  • Clinical Trial
  • Immunochemistry Test
  • GlobalData's company